2021 annual financial data
InMed Pharmaceuticals 2021 Operating margin
Direct answer
Operating margin was Not calculable.
Operating income was -12,171,142 CAD and net income was -12,649,279 CAD.
Operating cash flow was -9,790,640 CAD.
Get free InMed Pharmaceuticals email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 0 CAD
- Operating income
- -12,171,142 CAD
- Net income
- -12,649,279 CAD
- Operating cash flow
- -9,790,640 CAD